title: Intraperitoneal chemotherapy: a prolonged infusion of 5-fluorouracil using a novel carrier solution.
abstract: A novel carrier solution, icodextrin 20 (7.5%) has allowed exploration of prolonged intraperitoneal (IP) infusion of the cytotoxic drug, 5-fluorouracil. Eighteen patients with intraperitoneal carcinomatosis were entered into a feasibility and pharmacokinetic study of prolonged regional (IP) chemotherapy.. Specialist nurses trained the patients to self-administer their own treatment via a permanent i.p. catheter. A twin bag delivery system was used to perform one exchange daily. It proved possible to deliver continuous (5 days per week) i.p. 5-fluorouracil at doses of 200 mg/m2 and 300 mg/m2 for up to 12 weeks. The toxicities seen were infective peritonitis, nausea and vomiting, lethargy and anorexia. This was a nurse-led study and the home-based therapy holds promise for patients with malignant peritoneal disease.
authors.forename: A
authors.initials: A
authors.lastname: Young
authors.forename: J
authors.initials: J
authors.lastname: Gilbert
authors.forename: M
authors.initials: M
authors.lastname: Sherman
authors.forename: D
authors.initials: D
authors.lastname: Chatwin
authors.forename: J
authors.initials: J
authors.lastname: Budden
mesh_terms: D000328:Adult; D000368:Aged; D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use*; D015314:Dialysis Solutions / Q000627:therapeutic use*; D004337:Drug Carriers; D005240:Feasibility Studies; D005260:Female; D005472:Fluorouracil / Q000627:therapeutic use*; D006801:Humans; D007263:Infusions, Parenteral; D008297:Male; D008875:Middle Aged; D010530:Peritoneal Dialysis / Q000379:methods / Q000451:nursing; D010534:Peritoneal Neoplasms / Q000188:drug therapy*
chemical_list: D000964:Antimetabolites, Antineoplastic; D015314:Dialysis Solutions; D004337:Drug Carriers; D005472:Fluorouracil